Exploring Barriers to Buprenorphine Access for Opioid Use Disorder

Data to Support Drug Product Communications

Documents and Forms

Document Name Document Type
Attachment A_Recruitment_Buprenorphine_August 1 2024.docx Other-Recruitment
Attachment C_Questionnaire_Buprenorphine_August 1 2024.docx Other-Questionnaire
Attachment B_Screener_Buprenorphine.docx Other-Screener
Attachment D-IRB Letter_July_2024.pdf IRB Letter IC Document
0695 OMB Memo-Buprenorphine Barriers.docx OMB memo IC Document

Information Collection (IC) Details

IC Title:	Exploring Barriers to Buprenorphine Access for Opioid Use Disorder	Agency IC Tracking Number:	CDER

IC Status: New

Obligation to Respond: Voluntary

CFR Citation:

Information Collection Instruments:

Document Type	Instrument File	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability
Other-Recruitment	Attachment A_Recruitment_Buprenorphine_August 1 2024.docx	Yes	Yes	Fillable Printable
Other-Questionnaire	Attachment C_Questionnaire_Buprenorphine_August 1 2024.docx	Yes	Yes	Fillable Printable
Other-Screener	Attachment B_Screener_Buprenorphine.docx	Yes	No	Fillable Printable

Line of Business: Health

Subfunction: Consumer Health and Safety

Privacy Act System of Records
Title:	FR Citation:

Number of Respondents: 3,000	Number of Respondents for Small Entity: 0

Affected Public: Individuals or Households

Percentage of Respondents Reporting Electronically: 100 %

	Approved	Program Change Due to Agency Discretion
Annual Number of Responses for this IC	3,000	3,000
Annual IC Time Burden (Hours)	348	348
Annual IC Cost Burden (Dollars)	0	0

Documents for IC

Title	Document	Date Uploaded
IRB Letter	Attachment D-IRB Letter_July_2024.pdf	08/01/2024
OMB memo	0695 OMB Memo-Buprenorphine Barriers.docx	03/26/2025

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.